Healthcare Global Enterprises Limited (HCG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has a cash flow conversion efficiency ratio of 0.193x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.92 Billion ≈ $20.79 Million USD) by net assets (Rs9.94 Billion ≈ $107.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see HCG market cap for the company's overall valuation and market capitalisation.
Healthcare Global Enterprises Limited - Cash Flow Conversion Efficiency Trend (2011–2026)
This chart illustrates how Healthcare Global Enterprises Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Healthcare Global Enterprises Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Healthcare Global Enterprises Limited ranked by their cash flow conversion efficiency. Explore cash flow quality index of Healthcare Global Enterprises Limited to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CHIPMOS TECH.ADR 20 TA10
F:CPIA
|
0.079x |
|
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
|
-0.062x |
|
Imperial Metals Corporation
TO:III
|
0.066x |
|
Atresmedia Corporación de Medios de Comunicación S.A.
MC:A3M
|
0.049x |
|
Shanghai Yct Electronics Group Co.Ltd
SHE:301099
|
N/A |
|
Marcus & Millichap Inc
NYSE:MMI
|
0.048x |
|
Jiangsu Shagang Co Ltd
SHE:002075
|
0.072x |
|
TRUSTPILOT GROUP LS -01
F:6VZ
|
N/A |
Annual Cash Flow Conversion Efficiency for Healthcare Global Enterprises Limited (2011–2026)
The table below shows the annual cash flow conversion efficiency of Healthcare Global Enterprises Limited from 2011 to 2026. View latest Healthcare Global Enterprises Limited stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs14.10 Billion ≈ $152.51 Million |
Rs3.47 Billion ≈ $37.54 Million |
0.246x | -23.15% |
| 2025-03-31 | Rs9.90 Billion ≈ $107.07 Million |
Rs3.17 Billion ≈ $34.29 Million |
0.320x | -2.63% |
| 2024-03-31 | Rs8.65 Billion ≈ $93.56 Million |
Rs2.85 Billion ≈ $30.78 Million |
0.329x | +13.67% |
| 2023-03-31 | Rs8.69 Billion ≈ $94.02 Million |
Rs2.52 Billion ≈ $27.21 Million |
0.289x | +16.17% |
| 2022-03-31 | Rs8.84 Billion ≈ $95.57 Million |
Rs2.20 Billion ≈ $23.81 Million |
0.249x | +47.57% |
| 2021-03-31 | Rs7.14 Billion ≈ $77.22 Million |
Rs1.21 Billion ≈ $13.03 Million |
0.169x | -45.55% |
| 2020-03-31 | Rs4.20 Billion ≈ $45.40 Million |
Rs1.30 Billion ≈ $14.07 Million |
0.310x | +64.35% |
| 2019-03-31 | Rs5.22 Billion ≈ $56.47 Million |
Rs985.04 Million ≈ $10.65 Million |
0.189x | +11.67% |
| 2018-03-31 | Rs5.79 Billion ≈ $62.62 Million |
Rs978.13 Million ≈ $10.58 Million |
0.169x | -9.29% |
| 2017-03-31 | Rs4.90 Billion ≈ $53.00 Million |
Rs912.79 Million ≈ $9.87 Million |
0.186x | +16.66% |
| 2016-03-31 | Rs4.59 Billion ≈ $49.59 Million |
Rs731.97 Million ≈ $7.92 Million |
0.160x | -44.47% |
| 2015-03-31 | Rs2.08 Billion ≈ $22.44 Million |
Rs596.53 Million ≈ $6.45 Million |
0.287x | +57.70% |
| 2014-03-31 | Rs2.82 Billion ≈ $30.51 Million |
Rs514.22 Million ≈ $5.56 Million |
0.182x | +73.35% |
| 2013-03-31 | Rs2.96 Billion ≈ $32.01 Million |
Rs311.26 Million ≈ $3.37 Million |
0.105x | +4206.51% |
| 2012-03-31 | Rs2.19 Billion ≈ $23.73 Million |
Rs-5.62 Million ≈ $-60.78K |
-0.003x | -102.04% |
| 2011-03-31 | Rs1.76 Billion ≈ $19.08 Million |
Rs221.98 Million ≈ $2.40 Million |
0.126x | -- |
About Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more